Group 1 - The independent directors of Shenzhen BGI Tech Co., Ltd. held a special meeting to review the proposed adjustments to the daily related party transactions for the year 2025 [1] - The adjustments to the daily related party transaction limits are deemed necessary for the company's actual business operations and are based on changes in the related party structure and adjustments in business volume with certain related enterprises [1] - The pricing of the transactions is based on market principles and fair negotiation among the parties involved, ensuring that there is no harm to the interests of the company and its shareholders, particularly minority shareholders [1]

Group 1 - The company held its 15th meeting of the second board on July 8, 2025, and approved the establishment of a special fundraising account for the "BGI Intelligent Manufacturing R&D Center Project" [1] - The company aims to standardize the management of raised funds and protect the rights of small and medium investors, in accordance with relevant regulations from the China Securities Regulatory Commission and the Shanghai Stock Exchange [1] - The company previously approved the addition of Wuhan Intelligent Manufacturing Co., Ltd. as the implementation entity for the "BGI Intelligent Manufacturing R&D Center Project" and the use of self-owned funds to pay for R&D personnel costs, which will later be replaced with raised funds [2] Group 2 - The company will transfer the required funds for the project to the special fundraising account of Wuhan Intelligent Manufacturing through capital increase or borrowing [2] - The board authorized the financial officer to open the special fundraising account for Wuhan Intelligent Manufacturing and to sign relevant agreements with the commercial bank and sponsor regarding the supervision of the fundraising account [2]

Core Viewpoint - The company, Shenzhen Huada Zhizao Technology Co., Ltd., has proposed adjustments to its expected daily related transaction limits for the year 2025, which have been reviewed and approved by its board of directors and independent directors, ensuring compliance with relevant regulations and maintaining fair pricing principles [1][2][9]. Group 1: Daily Related Transactions Overview - The total expected amount for daily related transactions in 2025 is projected to be no more than 1,224.56 million yuan, with significant portions allocated for purchasing goods and services (327.79 million yuan) and selling goods and providing services (852.80 million yuan) [1]. - The adjustments include an increase of 5.90 million yuan for sales to related parties, 0.30 million yuan for services provided to related parties, and 16.03 million yuan for services purchased from related parties [3]. Group 2: Approval Process - The second board meeting on January 17, 2025, approved the expected daily related transaction limits, with related directors abstaining from voting [2]. - The independent directors unanimously agreed to submit the proposal for adjustments to the board for review on July 8, 2025, which was subsequently approved by the board and the supervisory board [8][9]. Group 3: Necessity and Fairness of Transactions - The adjustments are deemed necessary due to changes in the related party structure and the need for the company to align its transaction limits with actual business operations [3][10]. - The company emphasizes that all transactions will adhere to fair pricing principles, ensuring that they do not harm the interests of the company or its shareholders, particularly minority shareholders [10]. Group 4: Related Parties Information - The related parties involved include various joint ventures and subsidiaries of Huada Gene, with specific details on their business operations and ownership structures provided [4][5]. - The company has established a unified management system for its joint ventures to streamline transaction limits and ensure compliance with market principles [7]. Group 5: Audit and Compliance - The audit committee has reviewed the adjustments and confirmed that they align with the company's operational needs and comply with legal regulations [10]. - The sponsor institution, CITIC Securities, has also verified that the necessary internal approval processes were followed, and there are no objections to the proposed adjustments [10].

Core Viewpoint - Shenzhen BGI Intelligent Manufacturing Technology Co., Ltd. plans to cancel part of the restricted stock incentive plan for 2024 due to certain conditions not being met, including the departure of some incentive targets and failure to achieve performance assessment indicators [2][11][14]. Group 1: Approval and Authorization - The company has obtained necessary approvals and authorizations for the cancellation of the restricted stock, in accordance with relevant laws and regulations [11][17]. - The approval process included resolutions from the board of directors and supervisory board, as well as independent director opinions [7][10]. Group 2: Specifics of the Cancellation - A total of 337,150 shares of the second category of restricted stock will be canceled, which includes 188,000 shares due to 13 incentive targets leaving the company and 318,350 shares due to unmet performance criteria [11][14]. - The performance assessment for the incentive plan is based on the company's revenue growth, with a baseline of 2.709 billion yuan for 2023 [12][13]. Group 3: Information Disclosure - The company will disclose relevant documents related to the cancellation, including resolutions from the board and supervisory board meetings [15][16]. - The company is required to continue fulfilling its information disclosure obligations as per applicable laws and regulations [16][17].

证券代码：688114 证券简称：华大智造 公告编号：2025-044 深圳华大智造科技股份有限公司 一、本激励计划已履行的相关审批程序和信息披露情况 1、2024 年 6 月 11 日，公司召开第二届董事会第六次会议，会议审议通过 了《关于〈公司 2024 年限制性股票激励计划（草案）〉及其摘要的议案》《关 于公司〈2024 年限制性股票激励计划实施考核管理办法〉的议案》以及《关于 提请公司股东大会授权董事会办理股权激励相关事宜的议案》等议案。同日，公 司召开第二届监事会第六次会议，审议通过了《关于公司〈2024 年限制性股票 激励计划（草案）〉及其摘要的议案》《关于公司〈2024 年限制性股票激励计 划实施考核管理办法〉的议案》《关于核实公司〈2024 年限制性股票激励计划 激励对象名单〉的议案》等议案，公司监事会对本激励计划的相关事项进行核实 并出具了相关核查意见。 2、2024 年 6 月 12 日，公司在上海证券交易所网站（www.sse.com.cn）披露 了《关于独立董事公开征集委托投票权的公告》（公告编号：2024-037）。根据 1 公司其他独立董事的委托，独立董事许怀斌作为征集人就 202 ...

中信证券股份有限公司 关于深圳华大智造科技股份有限公司 2025 年度日常关联交易调整暨增加预计额度的核查意见 上海证券交易所: 中信证券股份有限公司（以下简称"中信证券"）作为深圳华大智造科技股 份有限公司（以下简称"华大智造"或"公司"）首次公开发行股票并在科创板 上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交易所科 创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号—— 规范运作》等相关规定履行持续督导职责，对华大智造 2025 年度日常关联交易 调整暨增加预计额度事项进行了审慎核查，具体核查情况如下： 1 度的议案》提交董事会审议。同日，公司召开第二届董事会第十五次会议、第二 届监事会第十四次会议审议通过了《关于 2025 年度日常关联交易调整暨增加预 计额度的议案》，关联董事汪建、牟峰、刘龙奇、余德健、朱岩梅已对此议案回 避表决。 基于关联方体系范围调整、公司及子公司存在与部分关联方企业调整业务量 的情形，公司拟调整 2025 年度部分日常关联交易预计额度，其中调增向关联方 销售商品额度 590 万元；调增向关联方提供服务额度 30 万元；调增向关联方采 购服务 ...

深圳市福田区中心四路 1-1 号 嘉里建设广场第三座第 2803-04 室 邮编：518048 电话：(86-755) 2939-5288 传真：(86-755) 2939-5289 北京市君合（深圳）律师事务所 关于深圳华大智造科技股份有限公司 2024 年限制性股票激励计划作废部分限制性股票事项的 其各自的合法持有人持有；其所提供的文件及文件上的签名和印章均是真实的； 其所提供的文件及所述事实均为真实、准确和完整；所有已签署或将签署文件的 各方，均依法存续并取得了适当授权以签署该等文件。对于出具本法律意见书至 关重要而又无法得到独立的证据支持的事实，本所依赖政府有关部门、公司或其 他相关方出具的有关证明、说明文件作出判断。 本所仅根据中国现行有效的法律、法规和规范性文件的有关规定发表法律意 见，并不依据任何中国境外法律发表法律意见。本所仅对本法律意见书出具之日 以前已经发生或存在的且与本次作废有关的重要法律问题发表意见，并不对公司 本次激励计划所涉及的标的股票价值、授予价格、业绩考核目标等问题的合理性 以及会计、财务、审计、投资决策等非法律专业事项发表意见。本所律师在本法 律意见书中对于有关会计、审计等专 ...

证券代码：688114 证券简称：华大智造 公告编号：2025-043 （一）关于 2025 年度日常关联交易预计额度履行的审议程序 根据深圳华大智造科技股份有限公司（以下简称"公司"）日常关联交易的 实际情况，并结合公司业务发展的需要，公司预计 2025 年度将与关联方发生的 日常关联交易总金额不超过 122,456 万元，关联交易主要内容包括向关联方采购 商品及服务、向关联方销售商品及提供服务、向关联方租赁房屋、向关联方出租 房屋、向关联方出租设备、其他收入、其他支出以及授权许可业务。其中，采购 商品及服务的关联交易金额为 32,779 万元，销售商品及提供服务的关联交易金 额为 85,280 万元，其余向关联方租赁房屋及出租房屋、出租设备业务、其他收 1 入支出以及授权许可业务的关联交易金额为 4,397 万元。 深圳华大智造科技股份有限公司 关于 2025 年度日常关联交易调整暨增加预计额度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●本事项无需提交公司股东大会审议。 ●日常关联交易对公司的 ...

深圳华大智造科技股份有限公司 2025 年 7 月 9 日 1 一、 关于 2025 年度日常关联交易调整暨增加预计额度的审查意见 公司本次调整 2025 年度日常关联交易额度事项符合公司日常经营业务实际需要， 本次调整系基于关联方体系范围调整、公司及子公司存在与部分关联方企业调整业务 量的情形，交易事项在关联各方平等协商的基础上按照市场价格的定价原则进行，遵 循了一般商业原则，交易定价公允，不存在损害公司及股东利益，特别是中小股东利 益的情形。我们一致同意将该议案提交董事会审议，审议本议案时，关联董事需回避 表决。 独立董事：李正、许怀斌、杨祥良、孙健 第二届董事会独立董事 2025 年第二次专门会议的审查意见 我们作为深圳华大智造科技股份有限公司（以下简称"公司"）的独立董事，根 据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司独立董事管理办 法》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律 监管指引第 1 号——规范运作》等法律法规、上海证券交易所业务规则以及《公司章 程》和《独立董事工作制度》等公司内部制度的相关规定，召开第二届董事会独立董 事 2025 年第二次 ...

证券代码：688114 证券简称：华大智造 公告编号：2025-045 深圳华大智造科技股份有限公司 关于增设募集资金专户的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 深圳华大智造科技股份有限公司（以下简称"公司"）于 2025 年 7 月 8 日 召开第二届董事会第十五次会议，审议通过了《关于增设募集资金专户的议案》， 同意作为"华大智造研发中心项目"实施主体的武汉华大智造科技有限公司（以 下简称"武汉智造"）增设募集资金专户，该事项无需经股东大会审议。具体内 容如下： 为规范公司募集资金管理，保护中小投资者的权益，根据中国证监会《上市 公司募集资金监管规则》《上海证券交易所科创板股票上市规则》《上海证券交 易所科创板上市公司自律监管指引第 1 号——规范运作》等有关规定，募集资金 应当存放于经董事会批准设立的专项账户集中管理和使用。 公司已于 2025 年 4 月 28 日召开第二届董事会第十三次会议、第二届监事会 第十三次会议，审议通过了《关于部分募投项目延期、增加实施主体与实施地点 及使用自有资金支付研发 ...